![微環(huán)載體介導肝再生增強因子的肝纖維化的治療_第1頁](http://file2.renrendoc.com/fileroot_temp3/2021-11/24/2aa50f11-fad3-4e99-9ead-6456d03bc0f0/2aa50f11-fad3-4e99-9ead-6456d03bc0f01.gif)
![微環(huán)載體介導肝再生增強因子的肝纖維化的治療_第2頁](http://file2.renrendoc.com/fileroot_temp3/2021-11/24/2aa50f11-fad3-4e99-9ead-6456d03bc0f0/2aa50f11-fad3-4e99-9ead-6456d03bc0f02.gif)
![微環(huán)載體介導肝再生增強因子的肝纖維化的治療_第3頁](http://file2.renrendoc.com/fileroot_temp3/2021-11/24/2aa50f11-fad3-4e99-9ead-6456d03bc0f0/2aa50f11-fad3-4e99-9ead-6456d03bc0f03.gif)
![微環(huán)載體介導肝再生增強因子的肝纖維化的治療_第4頁](http://file2.renrendoc.com/fileroot_temp3/2021-11/24/2aa50f11-fad3-4e99-9ead-6456d03bc0f0/2aa50f11-fad3-4e99-9ead-6456d03bc0f04.gif)
![微環(huán)載體介導肝再生增強因子的肝纖維化的治療_第5頁](http://file2.renrendoc.com/fileroot_temp3/2021-11/24/2aa50f11-fad3-4e99-9ead-6456d03bc0f0/2aa50f11-fad3-4e99-9ead-6456d03bc0f05.gif)
版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、微環(huán)載體介導肝再生增強因子的肝纖維化的治療researcharticlesaugme nterofliverrege nerati ongen etherapyusi nganovelminicirclednavectoralleviateslive rfibrosisinrats1,221,21,223xinwu,guangzeliu,maomu,yuti ngpe ngxiumeili 丄 iside ng,221,*andxia ngpingkon g2?*zhe nweizha ngmeijua nchens on gyou,instituteoflifescie ncea ndbio
2、 pharmaceuticsshenyangpharmaceuticalu niversit y,she ny ang,china;2keylaboratoryofliverdiseasezcentreoflnfectiousdiseases,458thhospitalofpla,guangzhou,china;3thefifthaf ?liatedhospital,s un yat-se nun iversity,zhuhai,chi na.1liver?brosisresultsi ncirrhosis,liverca ncera ndliverfailur 巳 whichisamajor
3、causeof mortalityworldwide.ge netherapyisarelatively newparadigminmedicinewithen ormoustherapeuticpote ntial.thedevelopme ntofa nef?cie ntan dsafedeliverysyst emisesse ntialforcli nicalge netherapy.lnthepresentstudyweevaluatedaugmenter ofliverrege neratio n/growthfactorervllike(alr/gfer)gen ethera p
4、euticeffect mediatedbya no velminicirclevector(mc-halr).theresultsinliver?broticratsthatr eceivedmc-halrthroughhydrod yn amics-basedtra nsfection(hbt)for8weeksindi catedthattheminicirclednavectorproducedamoreeffectivege netherapyeffectth an traditio nalplasmids(pcdna3.1halr).eve nwhe nwereducedthetr
5、eatmentdos eofmc-halrto30%(w/w)a ndthetreatme ntfreque ncyfromweeklytobiweekly,th einvitroa ndinvivoresultsstilldemonstratedthathigheralrge neexpressio nsigni? cantlyblockedincreasesi ntransforminggrowthfactorbl(tgfbl),plateletderived growthfactor-bb(pdgf-bb)/anda-smoothmuscleaorta(a-sma)levels;effe
6、ctively suppressedtheproductio no fcollage nsespeciallycollage nl;andeffectivelyalleviat edliverinjurya nd?brosisi nratsherebyimprovi ngthesurvivalrateofliver?broticrat s.ltispreliminarilyc oncl udedthattherelativeoverexpressionofmchalrinhibitsth eactivati ono fhepaticstellatecells(hscs),therebyalle
7、viati ngliver?brosisinrats keywords:minicirclednavector,high-levelexpression,augm en terofliverrege nera tion(alr),ge netherapy川 ver?brosis,hydrod yn amics-basedtra nsfection(hbt)introductionliverfibrosisresultsfromchronicdamagetotheliverinconjunctionwiththeex cessiveaccumulati ono fextracellularmat
8、rix(ecm)proteins,whichisacharacteristic ofchronicliverdiseasescausedbyviralautoimmunedrug-relatedholestaticorm etabolicdiseases.advancedliver?brosisresultsincirrhosisjiverca ncer;andliverfail ure,whichisamajorcauseofmortalityworldwide.lgen etherapyisarelativel yn ewparadigminmedicine,withe normousth
9、erapeuticp ote ntial.a ndliver-targetedge nedeliveryhasattractedagreatdealofatte ntion.21 na dditio ntowellk no wngrowthfactorszsuchashepatocytegrowthfactor(hgf)a ndep idermalgrowthfactor(egf),aug-menterofliverrege neration(alr),alsok nown asgr owthfactorervl-like(gfer),isanothercyto-kin eofvitalimp
10、orta ncetoliver3,4alrisamemberofthe newlydiscoveredalr/erv lproteinfamilywithfad-linkedsulfhydryloxidaseactivitythatcatalyzesdisul?debo n dformatio n.5,6thecxxcmotifofalrisesse ntialforcellsurvival7a ndthebioge nesi sofcytosolicfe/sproteins.8ln-deed?alrhasbee ndem on stratedtofunctio nasasur vivalfa
11、ctorforhepatocytes,a ndthedepleti ono falrproteinbya ntise nseolig onucle otidesleadstohepatocytecelldeath.7alrpromotesthegrowthofhepatocytesinth eregeneratingorinjuredliver,3,7playsapivotalroleasanimmunoregulatora ndasa n enzymeactivator,9?10andprotectshepatocytesagainstapoptosis.4furthermore,v ari
12、ousreportsi ndicatethatalrappearstobea no velimporta ntcytokinewithpote nti alcli nicalsig ni?cancei nthege netherapyofliver?brosis.!x12*corresponde nce:prof.s on gyoujnstituteoflifescie ncea ndbio pharmaceutics,s henyangpharmaceuticaluniversitno.loswenhuaroadjlooieshenyanghi n a.e-mail:yous on g206
13、;orprof.xiangpingk on g,keylaboratoryofliverdi seasezcentreofl nfectiousdiseases,458thhospitalofpla,gua ngzhou,chinaemaii:xia ngping_k on g880jhumangenetherapwlume27numberlla2016bymarya rmliebertjnc.d0l:10.1089/hum.2016.006 minicircle-mediatedalrgenetherapy881nevertheless,o neofthemajorbarrierstoalr
14、ge netherapyisthesafetya ndef?ci enc yofthevectorsusedforge netra nsferi neukaryoticcells.comparedwithviralvectors, non viralvectorsaresafeandsimpletopreparea ndmodify.l3plasmiddnaisfreque n tlyusedfor non viralge netherapy,butthepresen ceofcpgmotifsa ndtheiras-sociat edsequencesi nbacterialdnacause
15、sanimm uno toxicresponseafterthedeliveryoft heseplasmidvectorstomammalia nhosts,whichisapote ntialriskforsafecli nicalapp licatio nsan dreducestra nsgeneexpressio n.l4moreover;theresultsofourprevious experime ntdemo nstratedlowlevela ndshorttermexpressio ninresp on setoplas mid mediatedalrge nethera
16、pyi nrats,withlargei ndividualdifferences(unpublish edj.there-forethedevelopmentofa nef?cie ntan dsafedeliverysystemisessentialf oralrge netherapyminicircles(ivics),novelplasmiclbasedvectorsthatarecompo sedsolelyofeukaryoticsequencesd ono tcarryeitherantibioticresista ncege nesorb acterialorigi nsof
17、replicati on ;thus,mcsi nducemarkedlyreducedimmu nean din?a mmatoryresp on sesandeffectivelyprotecttransgeneexpressio nfrombeingsile nee dbecauseoftheprese nceofbacterialbackb on ese q uences15theuseofmcsisa nin terestingap-proachtoi ncreasethesafetya ndef?ci en cyofplasmid basedvectorsfor clinicalg
18、e netherapy.16therefore,i nthepresentstudy,a nalrexpressi on cassettei naminicirclednavector waspre-paredforthe?rsttime,theexpressi on levelofthealrge nemediatedbyami n icirclednavectorwascomparedwiththatofc onven tionalplasmidsbothinvitroa ndi n vivoa ndthe8weekge netherapyeffectin?broticratswascom
19、pared.materialsandmethodspare ntalplasmidc on structio nthehuma nalrgeneexpressi onf ragmentcontainingacmvpromoter,huma nalrc odin gseque nce(ge nban kaccessi onnu mber:nm_005262)?a ndbghpolyade nylati onsignalsequencewaspcr-ampli?edwithaforwardprimer(5 c -gactgaagatctatgtacgggccagatata-3 c )?revers
20、eprimer(5 c -ataccgctcgagggttctttccgcctcagga-3 c )zandprimestarmaxdnapoly-m erase(takara),usingthepreviouslyc on structedpcdna3.1-halr12asatemplate.th eampli?edfragme ntswereexcisedwithbgllla ndxhol(neb)a ndthe nligatedbetwee nattbandattpsites(fig.la,parentalplasmid).plasmidpreparatio napreviouslyre
21、portedprotocoll7forminicirclednavectorproductio nwasusedwit hsomemod-i?cations.brie?y,escherichiacolistrainzy-cy10p3s2t(akindgiftfromdr.zhiyingch en ,sta nforduniversity)wastra nsformedwiththepare ntalplasmids. on etra nsform an twaspickeda ndgrow no ver night(od6004.5-5.0)i n5mltbbroth(ln vitroge n
22、)con tainin gka namyci n( 50lg/ml)at37°cwithshaki ngat250rpn%followedbyampli?catio n with0.1-0.3%oftheinoculumintbbrothc on tainingka namycin(50lg/ml)for:15hr then,aftertheadditio no fal.2-foldvolumeoflbbroth(l nvitroge n)con taining0.03% l-arabi no se(sigma-aldrich)a nd3%lnnaoh,thei ncubati on wasc ontinu edfora nad ditional6hrat32°cwithshakingat250rpm.e.colistrai ndh5a(l nvitrogen)wastransformedwithpcdna3.1halr.onetransfo rmantcolonywaspickedandgrow no vernight(od6004.5-5.0)i n5mllbbroth(l nvitr oge
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 物聯(lián)網(wǎng)時代的網(wǎng)絡安全技術及管理策略
- 3 桂花雨(說課稿)-2024-2025學年統(tǒng)編版語文五年級上冊
- 2023九年級數(shù)學上冊 第2章 一元二次方程2.2 一元二次方程的解法2.2.1 配方法第3課時 用配方法解二次項系數(shù)不為1的一元二次方程說課稿 (新版)湘教版
- Unit 6 Food Lesson 1(說課稿)-2024-2025學年人教精通版(2024)英語三年級上冊001
- 2025房地產(chǎn)委托合同書范本
- 2023九年級數(shù)學上冊 第二十四章 圓24.2 點和圓、直線和圓的位置關系24.2.2 直線和圓的位置關系第3課時 切線長定理說課稿(新版)新人教版001
- 2《我愛我們的祖國》說課稿-2024-2025學年統(tǒng)編版語文一年級上冊
- Unit1 Making friends Part C Make a mind map of making friends(說課稿)-2024-2025學年人教PEP版(2024)英語三年級上冊
- 2《我是什么》(說課稿)2024-2025學年二年級上冊語文統(tǒng)編版
- 2025關于招標合同的報告
- 2025年上海用人單位勞動合同(4篇)
- 二年級上冊口算題3000道-打印版讓孩子口算無憂
- 新疆烏魯木齊地區(qū)2025年高三年級第一次質量監(jiān)測生物學試卷(含答案)
- 衛(wèi)生服務個人基本信息表
- 高中英語北師大版必修第一冊全冊單詞表(按單元編排)
- 新教科版科學小學四年級下冊全冊教案
- 苗圃建設項目施工組織設計范本
- 廣東省湛江市廉江市2023-2024學年八年級上學期期末考試數(shù)學試卷(含答案)
- 學校食品安全舉報投訴處理制度
- 安徽省蕪湖市2023-2024學年高一上學期期末考試 生物 含解析
- 北師大版八上《生物的遺傳和變異》
評論
0/150
提交評論